Sharp, part of UDG Healthcare plc, has invested £1 million ($1.24 million) in a commercial expansion project at its site in Rhymney, UK.   Since the Rhymney facility opened in late-2019, the company has received a number of enquiries for commercial primary and secondary packaging services.   After making the investment and receiving a commercial license in January of this year, Sharp can now meet demand for commercial packaging of a number of drug formats, including cold and thermoform blisters,...